Regencell Bioscience
Quarterly Financials
| Values in thousands | 2023-09-30 |
|---|---|
Gross Profit | -769 |
EBITDA | -1,082 |
EBIT | -1,082 |
Net Income | -1 |
Free Cash Flow | 1,539 |
Cash | 4,800 |
Basic Shares | 13,012 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -745 | -769 | -604 | -26 |
EBITDA | -3,617 | -5,292 | -6,990 | -1,354 |
EBIT | -4,363 | -6,062 | -7,594 | -1,381 |
Net Income | -4,301 | -5,871 | -7,422 | -1,346 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,007 | -4,990 | -6,047 | -767 |
Cash | 2,961 | 1,564 | 6,416 | 59 |
Basic Shares | 13,012 | 13,012 | 13,012 | 12,642 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-09-30 | -$0.30 |
2022-03-31 | -$0.29 |
2021-09-30 | -$0.11 |
2021-03-31 | -$29.80 |
